Benzydamine/econazole - Angelini Pharmaceuticals
Alternative Names: Benzydamine HCl and econazole nitrate - Angelini Pharmaceuticals; Benzydamine HCl/econazole nitrate - Angelini PharmaceuticalsLatest Information Update: 25 Feb 2022
At a glance
- Originator Angelini Pharmaceuticals
- Class Antifungals; Azoles; Dimethylamines; Fenamates; Imidazoles; Indazoles; Nonsteroidal anti-inflammatories; Propanolamines; Small molecules
- Mechanism of Action 14-alpha demethylase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Vulvovaginal candidiasis
Most Recent Events
- 25 Feb 2022 Benzydamine/econazole is still in phase III trials for Vulvovaginal candidiasis (In adults, In the elderly) in Bulgaria, Poland, Italy (Vaginal)
- 27 Mar 2018 Chemical structure information added
- 11 Oct 2017 Phase-III clinical trials in Vulvovaginal candidiasis (In adults, In the elderly) in Italy (Vaginal) (EudraCT2016-002808-19)